Conformal Wearable Battery
Search documents
Ultralife(ULBI) - 2025 Q4 - Earnings Call Transcript
2026-03-10 13:32
Financial Data and Key Metrics Changes - Q4 revenue reached $48.5 million, a 10.6% increase year-over-year, with an operating loss of $10.6 million resulting in a loss of $0.45 EPS [5][7] - Full year revenue for 2025 was $191.2 million, with over $30 million from new products, marking a 16.2% year-over-year growth, leading to a full year operating loss of $5.9 million and a loss of $0.35 EPS [5][6] - Consolidated gross profit was $12.1 million, up 13.7% from the previous year, with a gross margin of 24.9%, a 70 basis point improvement [9][10] Business Line Data and Key Metrics Changes - Battery and energy product segment revenues were $45.9 million, a 15.1% increase year-over-year, with organic growth driven by a 39.6% increase in medical and a 20.4% increase in industrial and other commercial sectors [7][8] - Communications Systems segment revenues declined to $2.6 million, a 35.2% decrease from the previous year, primarily due to delayed orders [8][9] Market Data and Key Metrics Changes - The sales split for the battery business was 73% commercial and 27% government defense, compared to 70% and 30% respectively in the previous year [8] - The backlog at the end of Q4 was $110.2 million, a 22.1% increase from the previous quarter, representing 58% of trailing twelve months sales [9][10] Company Strategy and Development Direction - The company aims to improve the profitability of its Communications Systems business and enhance gross margins in the battery and energy segment [16][17] - Strategic initiatives include transitioning to a unified brand, consolidating operations, and focusing on vertical integration opportunities following the acquisition of Electrochem [18][19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in 2026, citing a healthy backlog and several new product launches [6][25] - The company is targeting organic growth rates of at least double GDP and aims for EBITDA margins greater than 10% in the short term [27][28] Other Important Information - The company completed its ERP transition and operational initiatives to reduce costs during 2025 [5][6] - The transition of various sub-brands to the Ultralife master brand is expected to streamline operations and reduce costs [19][25] Q&A Session Summary Question: Growth and Margin Expansion Goals - Management indicated a roadmap to achieve organic growth and aims for a minimum of 2x GDP growth, targeting over 10% EBITDA margins in the short term [27] Question: Baseline Revenue for Communications Systems - Baseline revenue for the Communications Systems business is defined as $25 million, with potential for larger orders in the future [29] Question: Medical Order Ramp-Up - A new medical order is expected to generate a six-figure revenue stream annually, with initial product launches beginning soon [30][31]
Ultralife(ULBI) - 2025 Q4 - Earnings Call Transcript
2026-03-10 13:30
Financial Data and Key Metrics Changes - For Q4 2025, the company reported revenue of $48.5 million, a 10.6% increase year-over-year, with an operating loss of $10.6 million due to a one-time non-cash impairment, resulting in a loss of $0.45 EPS [5][14] - Full year 2025 revenue reached $191.2 million, with over $30 million from new products less than five years old, marking a growth of 16.2% year-over-year, leading to a full year operating loss of $5.9 million, equating to a loss of $0.35 EPS [5][14] - The consolidated gross profit for Q4 was $12.1 million, up 13.7% from the previous year, with a gross margin of 24.9%, a 70 basis point improvement from the prior year [10][11] Business Line Data and Key Metrics Changes - The battery and energy product segment generated revenues of $45.9 million, a 15.1% increase from the previous year, with organic growth driven by a 39.6% increase in medical and a 20.4% increase in industrial and other commercial sectors [8][9] - The Communications Systems segment saw revenues decline to $2.6 million, a 35.2% decrease from the previous year, primarily due to delayed orders from the U.S. government [9][10] Market Data and Key Metrics Changes - The sales split between commercial and government defense for the battery business was 73/27, compared to 70/30 in the previous year, indicating a shift towards more commercial sales [9] - The backlog at the end of Q4 was $110.2 million, a 22.1% increase from the previous quarter, representing 58% of trailing twelve months sales [10] Company Strategy and Development Direction - The company aims to improve profitability in the Communications Systems business and expects new product sales to drive growth in 2026 [6][19] - Strategic initiatives include transitioning various sub-brands to the Ultralife master brand and aligning battery and energy facilities under single leadership to maximize synergies [20][21] - The focus remains on operational efficiency, vertical integration, and expanding product offerings to drive organic growth [26][27] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in 2026, citing a healthy backlog and the completion of the Electrochem transition as key factors for future success [27] - The company is targeting organic growth rates of at least double GDP and aims for EBITDA margins greater than 10% in the short term [29][30] Other Important Information - The company completed the ERP transition and various operational initiatives to reduce ongoing costs during 2025 [5][6] - The company has received a refundable tax credit for certain qualifying battery cells and packs, which is expected to positively impact future financials [13] Q&A Session Summary Question: Growth and Margin Expansion Opportunities - Management discussed the roadmap for organic growth, targeting a minimum of double GDP growth and a short-term EBITDA margin of over 10% [29] Question: Baseline Revenue for Communications Systems Business - Management defined baseline revenue for the Communications Systems business as $25 million, with potential for larger orders in the future [32] Question: Medical Order Ramp-Up - Management indicated that a new medical order represents a six-figure plus opportunity per year, with initial product launches expected soon [34]